Silymarin ne Colorectal Kokoram Nhwehwɛmu ho nsɛm a wɔaka abom
Kokoram a ɛwɔ akyi berɛmo mu (CRC) yɛ nyarewa bɔne a abu so na edi awu sen biara wɔ wiase nyinaa no mu biako. Ɛmfa ho nkɔso a aba wɔ oprehyɛn, nnuru a wɔde sa yare, ayaresa a wɔde wɔn ani asi so, ne nnuru a ɛko tia nyarewa mu no, nea efi ayaresabea mu ba no da so ara sua esiane sɛ wohu yare no akyiri yi, nnuru a wɔko tia, nea efi mu ba, ne ayaresa ho ka kɛse nti. Nea afi mu aba ne sɛ, anigye a ɛrenya nkɔanim wɔ abɔde mu nneɛma a ɛwɔ dwumadi ahorow a wɔde asi wɔn ani so pii, ahobammɔ ho nsɛm a eye, ne abɔde mu nneɛma a ɛboa ho.
Silymarin a wɔfrɛ no silymarin, flavonolignan a ɛyɛ den a woyi fi muSilybum marianum a wɔfrɛ no silybum a wɔfrɛ no marianum(nufusu a wɔfrɛ no thistle), de adi dwuma bere tenten sɛ ade a ɛbɔ mmerɛbo ho ban. Wɔ nnansa yi mfe mu no, nyansahu mu adanse a ɛrenya nkɔanim kyerɛ sɛ silymarin nso da ne ho adianti-inflammatory, antioxidant, ne anti-akisikuru ahoɔden, a ɛma ɛyɛ ɔkannifo a ɔhyɛ bɔ ma kokoram-yɛ nhwehwɛmu a ɛfa kokoram ho.
Kratafa yi bɔ muanyansahu mu nsɛm a egyina nhwehwɛmu ahorow a wɔyɛe wɔ vitro, nnuru a wɔde di dwuma wɔ nkitahodi nhyehyɛe mu, molecule docking, ne protein a wɔda no adi nhwehwɛmu so, a ɛma yenya nhumu wɔanti-colorectal kokoram tumi a silymarin a wɔayiyi mu.
Adanse a Ɛwɔ Vitro: Colorectal Cancer Nkwammoaa Nnyin ne Tukɔ a Wosiw Ano
Nsɔhwɛ ahorow a egyina nkwammoaa- a wɔde nnipa colorectal kokoram nkwammoaa ahorow (RKO ne HCT-116) dii dwuma no daa no adi sɛ silymarin siw akisikuru nkwammoaa dwumadi ano kɛse:
Nkwammoaa a ɛtra ase no so tewwɔ dose-gyina ne bere-gyina kwan so
Wɔhyɛɛ colony a wɔhyehyɛ no ano, a ɛkyerɛ sɛ bere tenten-siw kokoram nkwammoaa a ɛdɔɔso ano
Nkwammoaa a wotu kɔ mmeae foforo no so tew, a ɛkyerɛ sɛ ebetumi ayɛ anti-metastatic nsunsuanso
Saa nneɛma a wɔahu yi kyerɛ sɛ silymarin siw kokoram nkwammoaa a ɛwɔ akyi berɛmo mu no abɔde mu nneyɛe atitiriw mu tẽẽ, a nea ɛka ho ne nyin ne sɛnea ɛkeka ne ho.
Network Pharmacology Analysis: Multi-Botae Akwan a Wɔde Di Dwuma
Nea ɛnte sɛ nnuru a wɔde yɛ nneɛma a wɔde asi wɔn ani so biako no, afifide mu nneɛma taa de abɔde mu nkɛntɛnso ba denamnnuru pii a ɛyɛ adwuma ne molecule botae ahorow pii. Wɔde network pharmacology nhwehwɛmu dii dwuma de huu akwan a ebetumi aba a ɛhyɛ silymarin anti-colorectal cancer dwumadi ase.
Botae Titiriw a Wɔbɛkyerɛ
Ɛdenam nsɛm a efi TCMSP, GeneCards, OMIM, DrugBank, PharmGKB, ne TTD databea ahorow a wɔde bɛka abom so no, .38 a wobetumi de ayɛ ayaresa botae ahorowa ɛfa kokoram a ɛwɔ akyi berɛmo mu ho no huu silymarin.
Protein–protein nkitahodi (PPI) nhwehwɛmu daa abiɛsa adimmara mu botae atitiriw:
PPARG (Peroxisome Proliferator-Agyefo a Wɔma Ɛyɛ Adwuma Gamma) .
PTGS2 (COX-2, Cyclooxygenase-2) na ɛyɛ adwuma wɔ ɔkwan a ɛyɛ nwonwa so.
Caspase-3 na ɛwɔ hɔ
Saa botae ahorow yi ne akisikuru a ɛma nipadua no yɛ adwuma, ɔfe, ne apoptosis wɔ abusuabɔ kɛse.
Dwumadi mu Enrichment ne Key Signaling Akwan
Gene Ontology (GO) ne KEGG kwan so ahonyade nhwehwɛmu daa no adi sɛ silymarin-fata botae ahorow no ka ho titiriw wɔ:
Abɔde a Nkwa Wom Ho Nneyɛe
Mmuae a wɔde ma wɔ oxidative stress ne xenobiotic stimuli ho
Lipid a ɛsakra no ho nhyehyɛe
Apoptotic nsɛnkyerɛnne akwan
Inflammatory mmuae a wɔsakra no
Akwan Titiriw a Wɔfa so Kyerɛkyerɛ
PI3K–Akt sɛnkyerɛnne kwan so
AGE–RAGE sɛnkyerɛnne kwan so
VEGF sɛnkyerɛnne kwan so
Efferocytosis (apoptotic nkwammoaa a wɔpopa) .
Lipid metabolism ne atherosclerosis-akwan a ɛfa ho
Nea afi mu aba yi si so dua sɛmulti-kwan so mmara tumi a silymarin wɔ, a ɛfa nyarewa a emu yɛ den te sɛ kokoram ho titiriw.
Molecular Docking: Nkitahodi a Ɛyɛ Den a ɛne Protein Titiriw Wɔ
Wɔyɛɛ molecule docking simulations de sii nkitahodi a ɛda silymarin active compounds ne core target proteins ntam no so dua.
Nea efii docking mu bae no kyerɛɛ ahoɔden a eye a ɛkyekyere:
PTGS2 (COX-2): Ɛyɛ −9.9 kcal/mol
PPARG: −9.2 kcal/mol
Caspase-3: −6.0 kcal/mol
Ahoɔden a ɛkyekyere a ɛba fam sen −5.0 kcal/mol taa kyerɛ molecule abusuabɔ a emu yɛ den, na ɛfoa adwene a ɛne sɛ silymarin nnuru betumi ne kokoram-fata botae ahorow adi nkitaho tẽẽ wɔ molecule gyinabea no so.
Protein Nkyerɛkyerɛmu Nhwehwɛmu: Apoptosis ne Ɔfe a Wɔhwɛ So
Western blot nhwehwɛmu sii so dua bio sɛ silymarin tumi a ɛhyɛ mmara so wɔ protein dodow mu:
Caspase-3 a wɔapaapae mu a wɔda no adi kɛse, a ɛkyerɛ sɛ apoptosis no yɛ adwuma
PPARG ne PTGS2 (COX-2) a wɔda no adi no so tew ., a ɛkyerɛ sɛ wosiw pro-tumor metabolic ne inflammatory akwan so
Saa nhwehwɛmu a wɔahu yi ne nea efii network pharmacology ne molecular docking analyses mu bae no hyia.
Nyansahu mu Nkyerɛase ne Tumi a Wɔde Di Dwuma
Nea afi mu aba a wɔaka abom no kyerɛ sɛsilymarin siw colorectal kokoram nkwammoaa a ɛdɔɔso ne atutra ano denam multi-botae ne multi{1}}kwan nhyehyɛe so, titiriw denam apoptosis, ɔfe, oxidative stress, ne metabolic signaling a wɔsakra no so.
Mmeae a Wobetumi De Adi Dwuma
Nutraceutical ne aduan a ɛyɛ adwuma ho nhwehwɛmu
Oncology-a ɛfa nneɛma a wɔde yɛ aduan ho nkɔso
Nnuru ne abɔde a nkwa wom ho nhwehwɛmu
Nnuru a wɔde ko tia-inflammatory ne antioxidant
Silymarin ahobanbɔ ho nsɛm a wɔde asi hɔ yiye ne abɔde mu mfiase no ma ne bo yɛ kɛse bio sɛ anhwehwɛmu-foa afifide mu nneɛma a wɔde yɛ aduan.
Nsɛm a Wɔka Kyerɛ
Wɔde saa nsɛm yi amanyansahu ne nhwehwɛmu mu nsɛm a wɔde gyina hɔ ma nkutoo.
Silymarin a wɔayi afi mu no yɛɛnyɛ nea wɔayɛ sɛ wɔde behu yare biara, asa, asa, anaa asiw ano.
Ɛsɛ sɛ akwammisa nkrataa no di mpɔtam hɔ mmara ahwehwɛde ahorow so.
Nea Enti a Eyi Ho Hia Ma Wiase Nyinaa Adetɔfo
Wɔ amanaman ntam adetɔfo, wɔn a wɔyɛ nnuru, ne Nhwehwɛmu ne Nkɔso akuw fam no, nyansahu mu adanse di dwuma titiriw wɔ nneɛma a wɔde yɛ aduan a wɔpaw mu. Nneɛma a wɔahu a wɔabobɔ so wɔ ha no da no adisilymarin a wɔayi afi mu no yɛ nea mfiridwuma mu nhwehwɛmu foa so, a ɛma ɛyɛ ade a ɛsom bo ma nkɔso foforo wɔ akwahosan-fa ho dwumadie mu.
